Slate Path Capital LP - Q3 2019 holdings

$1.51 Billion is the total value of Slate Path Capital LP's 29 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .

 Value Shares↓ Weighting
KEX  KIRBY CORP$112,148,000
+4.0%
1,365,0000.0%7.42%
+53.5%
GE  GENERAL ELECTRIC CO$92,529,000
-14.9%
10,350,0000.0%6.13%
+25.7%
ALNY  ALNYLAM PHARMACEUTICALS INC$49,458,000
+10.8%
615,0000.0%3.28%
+63.7%
ZG  ZILLOW GROUP INCcl a$5,466,000
-35.4%
185,0000.0%0.36%
-4.7%
TDW  TIDEWATER INC NEW$1,662,000
-35.7%
110,0000.0%0.11%
-5.2%
AG  FIRST MAJESTIC SILVER CORP$1,545,000
+14.9%
170,0000.0%0.10%
+70.0%
SDRLF  SEADRILL LTD$819,000
-49.5%
390,0000.0%0.05%
-26.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings